# OnCo record paper-aaml1031-sorafenib-flt3-pollard-jco-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aaml1031-sorafenib-flt3-pollard-jco-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aaml1031-sorafenib-flt3-pollard-jco-2022" ;
  schema:name "AAML1031: sorafenib combined with chemotherapy for children with high allelic ratio FLT3-ITD acute myeloid leukaemia"@en ;
  schema:description "Adding the kinase inhibitor sorafenib to chemotherapy improved event-free survival in children with high allelic ratio FLT3-ITD acute myeloid leukaemia compared with matched historical controls, the first FLT3-targeted result in paediatric leukaemia."@en ;
  schema:url <https://onco.cc/key-papers/paper-aaml1031-sorafenib-flt3-pollard-jco-2022/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.21.01612>, <https://pubmed.ncbi.nlm.nih.gov/35349331/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.21.01612> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Pollard JA, Alonzo TA, Gerbing R, et al." ;
  onco:cancers <https://onco.cc/cancers/aml-paediatric/> ;
  onco:drugs <https://onco.cc/drugs/sorafenib/> ;
  onco:journals <https://onco.cc/journals/jco/> .